Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

269
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/03/2015 Date
365.8 364.6 372.4 370.9 368.7 Last
3062441 3162297 2665560 2016075 1435199 Volume
-1.83% -0.33% +2.14% -0.40% -0.59% Change
Financials ( DKK)
Sales 2015 108 255 M
EBIT 2015 47 563 M
Net income 2015 33 247 M
Finance 2015 12 529 M
Yield 2015 1,62%
Sales 2016 117 668 M
EBIT 2016 51 182 M
Net income 2016 39 607 M
Finance 2016 14 458 M
Yield 2016 1,95%
PER 2015 28,70
PER 2016 23,84
EV / Sales 2015 6,91x
EV / Sales 2016 6,34x
Capitalization 760 467 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas... 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
07/02 NOVO NORDISK A/S : Will new diet drug prove safe, effective - and affordable?
07/02 NOVO NORDISK A/S : Share repurchase programme
07/02 NOVO NORDISK A/S : Between Health and Faith - Managing Diabetes During Ramadan
07/02 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
07/01 NOVO NORDISK A/S : Patent Issued for Therapeutic Factor VIII Antibodies
07/01 NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Obesity Reported (I..
07/01 NOVO NORDISK A/S : New Diabetes Study Findings Recently Were Reported by Researc..
07/01 NOVO NORDISK A/S : Findings from Novo Nordisk Provide New Insights into Transcri..
More news
Sector news : Pharmaceuticals - NEC
10:43a NOVARTIS : 'More efforts needed worldwide to prevent eye diseases'
01:00a OPKO HEALTH : and Bio-Reference Laboratories Announce Early Termination of the W..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/03 No Letting Up In Pharma As First-Half Gains Outweigh Losses
06/27 The Weekender
06/26 Emisphere's Undervalued Diabetes Pill Partnership Is An Oversized Opportunity
06/21 The Weekender
06/18 Expect Novo Nordisk To Commit To Their Late-Stage Diabetes Pill Development S..


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions